Search Results 81-90 of 18504 for IBS
The purpose of this study is to evaluate gastric, small-bowel, and colonic transit in subjects with IBS-C and IBS-D treated with multiple (three times daily) ...
Research. Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. Researchers in the Enteric ...
... irritable bowel syndrome (IBS) and functional constipation. Individuals with chronic and moderate to severe symptoms report that these symptoms negatively ...
... irritable bowel syndrome with diarrhea (IBS-D) or functional diarrhea (FD) who are HLA-DQ2 positive. Participation eligibility. Participant eligibility ...
Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. ... Mayo Clinic researchers also study IBS in the ...
Eluxadoline has been approved by the FDA for people with IBS-D but it is not known whether it will work the same way in people with IBS-D who also have BAM.
About this study. The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating IBS-D in pediatric patients 12-17 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.